Status:
COMPLETED
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Lead Sponsor:
Albany Medical College
Collaborating Sponsors:
Alere, Inc.
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
1-24 years
Brief Summary
The purpose of this study is to determine if B type natriuretic peptide (BNP) levels can be used to predict a hemodynamically significant patent ductus arteriosus (PDA). This peptide is produced by th...
Detailed Description
B type natriuretic peptide (BNP) is mainly synthesized in the ventricles of the heart and released in response to volume and pressure loading and ventricular stress and, therefore, plays an important ...
Eligibility Criteria
Inclusion
- gestational age between 24 0/7 weeks gestation and 31 6/7 weeks gestation. - Infants must be enrolled by 24 hours of life.
Exclusion
- congenital heart disease,
- necrotizing enterocolitis,
- culture positive sepsis or culture negative but treated for presumed sepsis.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01497054
Start Date
December 1 2011
End Date
April 1 2013
Last Update
July 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albany Medical Center Neonatal Intesive Care Unit
Albany, New York, United States, 12208